At a glance
ClinicalIndex Comparison RecordPhase 2Active· 100 target
Drug / intervention
CMTS4520 (dietary fiber and probiotics) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Efficacy and Safety of CMTS4520 for Chronic Diarrhoea in Adults： A Randomized, Double-Blind, Placebo-Controlled Trial.
The Second Hospital of Nanjing Medical University·interventional·Posted Feb 21, 2025·Updated Nov 18, 2025
In Brief
A Phase 2 clinical trial evaluating CMTS4520 (dietary fiber and probiotics) and Placebo for Diarrhoea. Active but no longer recruiting, targeting 100 participants across 1 site.
Detailed Summary
This is a randomized controlled trial to explore the efficacy and safety of CMTS4520 (Dietary Fiber Probiotics) for patients with chronic diarrhoea.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiarrhoea
CountriesChina
Collaborators--
Timeline
Phase 2Active
202520262027202820292030
Enrollment StartFeb 2025
First PostedFeb 2025
TodayJul 2026
Primary CompletionJan 2030
Study CompletionJul 2030
First PostedFeb 21, 2025
Enrollment StartFeb 20, 2025
Primary CompletionJan 31, 2030
Study CompletionJul 1, 2030
TodayJul 1, 2026
Enrollment to primary: 4.9 yearsPosted 1.4 years agoPrimary completion in 3.6 years
Interventions
CMTS4520 (dietary fiber and probiotics)drug
CMTS4520 is a synbiotic formulation containing a standardized ratio of plant-derived prebiotics and clinically validated probiotic strains. Participants will receive 4 weeks of CMTS4520 daily for chronic diarrhoea.
Placebodrug
Capsules with matching volume and consistent appearance to CMTS4520.